"We are determined to give you the best treatment in the world," Trump said during the signing of the executive order."We have made a lot of progress and we're with you every step of the way.Providing care for people with kidney disease is a big business in the US. For-profit companies DaVita, Fresenius and American Renal Associates operate centers where people can get dialysis, a procedure that filters the blood for people whose kidneys are failing.
Analysts at SVB Leerink led by Ana Gupte said that American Renal will be negatively impacted by the order as the company has not invested as much in home-based care, while competitors DaVita and Fresenius have been investing in this area of kidney health.on the Trump administration's plans late on Monday.In a statement, DaVita said it's already the largest provider of in-home dialysis in the US.
"We will continue to work with the Administration and Congress to launch programs that address broader care opportunities," said Javier Rodriguez, CEO for DaVita Inc in aBig insurance companies including CVS Cigna, UnitedHealth and Anthemcould benefit from the executive order, Gupte said, because they're investing in home-based dialysis. In-home dialysis is typically less costly, and can be more convenient for patients.
The second key area is to provide an increase in access to kidney transplants by modernizing the system and regulations. The administration outlined actions to expedite the process of kidney matching to increase transplants. The third key area is to give patients more choices and affordable treatments. This includes improving home dialysis treatment and improving kidney transplants. Currently 12% of people with kidney disease receive home dialysis, according to the Trump administration. The executive order will call for 80% of people to get care at home by 2025.